Literature DB >> 6847733

The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica.

P Doury, S Pattin, F Eulry, A Thabaut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6847733     DOI： 10.1002/art.1780260521

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Polymyalgia rheumatica/temporal arteritis: recent advances.

Authors:  Maria-Louise Barilla-LaBarca; Deborah J Lenschow; Richard D Brasington
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

Review 3.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 4.  Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.

Authors:  G Nesher; M Sonnenblick
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

5.  Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.

Authors:  Kim Heang Ly; François Dalmay; Guillaume Gondran; Sylvain Palat; Holy Bezanahary; Anne Cypierre; Anne-Laure Fauchais; Eric Liozon
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.